Forging the Frontiers of Cranial and Facial Surgery
The Klay Platform is an AI driven, revolutionary 3D software platform offering an unprecedented level of accuracy, predictability and patient control for cranial and facial surgical procedures.
Learn moreACCURATE, SEAMLESS AND PATIENT-CENTRIC
Our faces are our most unique and important visual assets. We believe in empowering every patient who needs to make a change to their head or face. In order to do so, the Klay Platform provides a real-time virtual tool for patient and doctor to collaboratively design the patient’s desired look and outcome.
The Klay Platform uses proprietary hardware and software solutions to plan, visualise, develop and execute procedures with unprecedented levels of control and accuracy. To have this ability to see the predicted outcome with such precision before surgery is exceptionally reassuring for patients and provides an invaluable tool for surgical teams.
About
The Klay Platform is built on our founding surgeons’ two decades of research and execution in improving surgery to the head and face. We’ve solved some of the most complex global challenges in this domain and continue to develop tools to assist doctors and surgical teams plan and deliver healthcare solutions to a degree that wasn’t possible before.
Our aim with the platform is to put the patient in control, at the centre of the intervention, allowing them to design their optimal outcome with the professionals. Enabling surgeons to predict the future in cranial and facial surgery and then following through exactly as planned is the foundation of Klay.
Product
The Klay Platform provides surgeons and their patients a fully texturised, high resolution 3D-model of the patient’s face, bone and tissue by combining our photogrammetry scanning technology with CT scans. Surgeons can then perform virtual surgery on the facial model using the Klay suite of design tools to 'see' the desired outcome with their patients.
The predictive engine behind the virtualised cranial and facial procedures is powered by AI and Finite Element algorithms. This is next level technology, driven by a patient-centric focus and precision healthcare.
Our Team
Senior management team
Owase Jeelani MPhil, MBA, FRCS
Co-Founder, Inventor & Paediatric Neurosurgeon
David Dunaway FRCE, CBE
Co-Founder Chairman, Inventor & Craniofacial Surgeon
Jeremy Littman
Co-Founder & Commercial NED
Hector Macleod
Co-Founder & Head of Software Development
Kalim Rahim MSc
Chief Executive Officer
Eimear O’Sullivan BEng, MRes, PhD
3D Modelling Engineer
- Owase is a world-renowned paediatric neurosurgeon, philanthropist, inventor and entrepreneur based at Great Ormond Street Hospital in London. Owase was the Head of the Neurosurgery Division at GOSH from 2012 until 2018. He established it as one of the largest paediatric neurosurgery services in the world and one of the flagship services at GOSH. His leadership and work have brought substantial international recognition to GOSH and the NHS. Owase is a Principal Investigator of FaceValue, a UCL-based research team of scientists and biomedical engineers that design machine-learning algorithms to predict and improve surgical outcomes. He’s also the inventor of CranioXpandTM, a cranial distractor system to make surgery safer and more cost-effective. In 2018 Owase founded Gemini Untwined, a global charity set up to assist and treat Craniopagus twins. Since then he has led on 3 further sets of Craniopagus twin separation procedures. Owase was ranked in Time Magazine’s top 100 surgeons in the UK in 2011 and the top 100 paediatric specialists in the UK in 2012.
- David is a global expert in Craniofacial Surgery and Cranial Morphometrics. He leads the Craniofacial Surgery Unit at Great Ormond Street hospital and is a Principal Investigator at FaceValue leading a team of biomedical and software engineers at UCL. His clinical and research focus over the past 25 years has been on developing devices and software platforms to improve outcomes in Craniofacial surgery. During his career, David has undertaken thousands of complex craniofacial procedures including four sets of Craniopagus twin separations. In 2016 he was awarded a CBE in recognition to his exceptional contribution to facial surgery, globally.
- Jeremy previously founded Engenie, now Osprey Charging, an EV charging business, which realised a £35m equity investment in 2019 achieving an 8x multiple return for early investors. This led to him founding the Exagen Group, a Smart Clean Energy Generator developing and operating utility scale renewable energy and battery storage plants able to solve the electricity grid imbalance caused by the booming market in renewable generation. His passion to contribute to a cleaner, healthier environment runs in parallel with Klay’s social mission to help improve patient’s wellbeing. Jeremy lends a mix of technical and commercial experience to the team, building the group into a sustainable, high-growth biotech venture.
- Hector set up Glassworks in 1996 and helped build and establish the world’s first open architecture VFX facility in New York. Initially they provided specialist higher-end visual effects to producers of commercials and pop promos. Utilising the skills of the deeply talented teams of artists within the VFX business, they established a special projects division, creating real-time interactive bespoke products in AR, VR and holographic displays. This led to building Heartworks for UCLH. This was a medical simulation, created by model builders and animators, which assisted in the teaching of cardiac anatomy and manikin-based simulation in echocardiography. It was a global success that inspired the foundation and development of The Klay Platform.
- Kalim started his career in M&A, at Macquarie Group, and subsequently led investments in and provided management support to many high growth, advanced technology businesses, as a venture capital investor. He is an Associate Partner at Eccleston Associates, a boutique London-based strategy firm, where he spearheads origination activities and provides Executive Leadership support for scaling small to mid-sized businesses, by delivering operational direction, fundraising support and driving growth. Kalim is an advisor to Kestral Group, an aerospace sector consulting firm, where he has in the past established commercial operations in Europe and the Middle East, while co-managing existing interests in Asia. Kalim is a Physicist with an MSc in Finance from the London Business School.
- Eimear received the BEng degree in electronic and computer engineering from the University of Limerick, Limerick, Ireland, and the MRes degree in medical robotics and image guided intervention from Imperial College London, London, United Kingdom, in 2016 and 2018, respectively. She completed her PhD in “Statistical Shape Modelling for Hard and Soft Tissue of the Human Head” at Imperial College London under the supervision of Prof. Stefanos Zafeiriou and is currently awaiting her viva. Her research interests include geometric deep learning, computer vision, and 3D facial landmark localisation for the analysis and characterization of craniosynostosis.
Owase Jeelani MPhil, MBA, FRCS
Co-Founder, Inventor & Paediatric Neurosurgeon
- Owase is a world-renowned paediatric neurosurgeon, philanthropist, inventor and entrepreneur based at Great Ormond Street Hospital in London. Owase was the Head of the Neurosurgery Division at GOSH from 2012 until 2018. He established it as one of the largest paediatric neurosurgery services in the world and one of the flagship services at GOSH. His leadership and work have brought substantial international recognition to GOSH and the NHS. Owase is a Principal Investigator of FaceValue, a UCL-based research team of scientists and biomedical engineers that design machine-learning algorithms to predict and improve surgical outcomes. He’s also the inventor of CranioXpandTM, a cranial distractor system to make surgery safer and more cost-effective. In 2018 Owase founded Gemini Untwined, a global charity set up to assist and treat Craniopagus twins. Since then he has led on 3 further sets of Craniopagus twin separation procedures. Owase was ranked in Time Magazine’s top 100 surgeons in the UK in 2011 and the top 100 paediatric specialists in the UK in 2012.
David Dunaway FRCE, CBE
Co-Founder Chairman, Inventor & Craniofacial Surgeon
- David is a global expert in Craniofacial Surgery and Cranial Morphometrics. He leads the Craniofacial Surgery Unit at Great Ormond Street hospital and is a Principal Investigator at FaceValue leading a team of biomedical and software engineers at UCL. His clinical and research focus over the past 25 years has been on developing devices and software platforms to improve outcomes in Craniofacial surgery. During his career, David has undertaken thousands of complex craniofacial procedures including four sets of Craniopagus twin separations. In 2016 he was awarded a CBE in recognition to his exceptional contribution to facial surgery, globally.
Jeremy Littman
Co-Founder & Commercial NED
- Jeremy previously founded Engenie, now Osprey Charging, an EV charging business, which realised a £35m equity investment in 2019 achieving an 8x multiple return for early investors. This led to him founding the Exagen Group, a Smart Clean Energy Generator developing and operating utility scale renewable energy and battery storage plants able to solve the electricity grid imbalance caused by the booming market in renewable generation. His passion to contribute to a cleaner, healthier environment runs in parallel with Klay’s social mission to help improve patient’s wellbeing. Jeremy lends a mix of technical and commercial experience to the team, building the group into a sustainable, high-growth biotech venture.
Hector Macleod
Co-Founder & Head of Software Development
- Hector set up Glassworks in 1996 and helped build and establish the world’s first open architecture VFX facility in New York. Initially they provided specialist higher-end visual effects to producers of commercials and pop promos. Utilising the skills of the deeply talented teams of artists within the VFX business, they established a special projects division, creating real-time interactive bespoke products in AR, VR and holographic displays. This led to building Heartworks for UCLH. This was a medical simulation, created by model builders and animators, which assisted in the teaching of cardiac anatomy and manikin-based simulation in echocardiography. It was a global success that inspired the foundation and development of The Klay Platform.
Kalim Rahim MSc
Chief Executive Officer
- Kalim started his career in M&A, at Macquarie Group, and subsequently led investments in and provided management support to many high growth, advanced technology businesses, as a venture capital investor. He is an Associate Partner at Eccleston Associates, a boutique London-based strategy firm, where he spearheads origination activities and provides Executive Leadership support for scaling small to mid-sized businesses, by delivering operational direction, fundraising support and driving growth. Kalim is an advisor to Kestral Group, an aerospace sector consulting firm, where he has in the past established commercial operations in Europe and the Middle East, while co-managing existing interests in Asia. Kalim is a Physicist with an MSc in Finance from the London Business School.
Eimear O’Sullivan BEng, MRes, PhD
3D Modelling Engineer
- Eimear received the BEng degree in electronic and computer engineering from the University of Limerick, Limerick, Ireland, and the MRes degree in medical robotics and image guided intervention from Imperial College London, London, United Kingdom, in 2016 and 2018, respectively. She completed her PhD in “Statistical Shape Modelling for Hard and Soft Tissue of the Human Head” at Imperial College London under the supervision of Prof. Stefanos Zafeiriou and is currently awaiting her viva. Her research interests include geometric deep learning, computer vision, and 3D facial landmark localisation for the analysis and characterization of craniosynostosis.
